NEUROENDOCRINE CARCINOMA OF THE SKIN

This adverse event was reported 979 times

These drugs are most commonly taken by patients reporting NEUROENDOCRINE CARCINOMA OF THE SKIN:

# Drug Count
0 METHOTREXATE SODIUM 139
1 PREDNISONE 128
2 METHOTREXATE 125
3 TACROLIMUS 101
4 TACROLIMUS EXTENDED-RELEASE CAPSULES 91
5 TACROLIMUS OINTMENT 0.1% 91
6 MYCOPHENOLATE MOFETIL 70
7 ADALIMUMAB 67
8 RITUXIMAB 63
9 INFLIXIMAB 57
See all common drugs associated with NEUROENDOCRINE CARCINOMA OF THE SKIN

NEUROENDOCRINE CARCINOMA OF THE SKIN is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TALIMOGENE LAHERPAREPVEC 11 0.0069
1 ALDESLEUKIN 3 0.0024
2 ANTI-THYMOCYTE GLOBULIN (RABBIT) 16 0.0020
3 BENDAMUSTINE HYDROCHLORIDE 16 0.0019
4 AZATHIOPRINE SODIUM 4 0.0016
5 SIROLIMUS 19 0.0014
6 BENDAMUSTINE HCL 17 0.0011
7 FINGOLIMOD HYDROCHLORIDE 5 0.0010
8 TOFACITINIB CITRATE 13 0.0010
9 ADALIMUMAB-FKJP 39 0.0008
See all drugs enriched for association with NEUROENDOCRINE CARCINOMA OF THE SKIN